Termal Çamurlara Moleküler Bakış

Termal tedavi kapsamında yaygın olarak kullanılan termal çamurlar (peloidler), genel olarak organik ve inorganik (mineral) iki ana madde grubundan oluşmaktadır. Organik yapı, onlarca yıllık zaman dilimlerinde, birçok kimyasal süreçten sonra oluşmaktadır ve oldukça kompleks bir yapıya sahiptir. Durgun su ortamı, bitkisel çeşitlilik, mikroorganizma çeşitliliği ve zaman bu yapının oluşmasında önemli rol oynamaktadır. Organik maddelerin tanımına yönelik ilk bilgiler, oldukça sınırlıdır. Son yıllarda GC-MS ve benzeri yöntemlerinin kullanım sıklığının artmasıyla günlük pratikte dikkatimizi çekmeyen birçok madde grubunun termal çamurların yapısında olduğu anlaşılmıştır. Biyolojik olarak aktif olan bu maddeler genel olarak; humik maddeler, karboksilik asitler, terpenoidler, steroidler, yağ asitleri gibi maddelerdir. Kozmetikten inflamasyona kadar birçok durumla ilgili bu farklı madde gruplarının termal çamurların yapı taşlarını oluşturması, termal çamurların tedavide kullanımlarını oldukça anlamlı kılmaktadır. Bu derlemede termal çamurların yapısını oluşturan molekül guplarına ait etkiler ortaya konulmaya çalışıldı.

Thermal Mud Molecular Overview

Thermal mud (peloids), which are frequently used for thermal therapy purposes consist of organic and inorganic (minerals) compounds in general. Organic structure is formed after a variety of chemical processes occurring in decades and comprise of a very complex structure. Stagnant water environment, herbal diversity, microorganism multiplicity and time are crucial players to form the structure. Data regarding description of organic compounds are very limited. Nowadays, it was clearly understood that a variety of compounds those are neglected in daily practice are found in thermal mud after GC-MS and similar methods are being frequently used. Those compounds which are biologically active are humic compounds, carboxylic acids, terpenoids, steroids and fatty acids. By comprising the thermal mud, these different compound groups which are related to divers areas from cosmetology to inflammation, make the thermal mud very meaningful in the treatment of human disease. In this review, it was tried to put forward the effects of several molecule groups those consisting of the thermal mud structure.

PDF

___

1. Eichelsdörfer D. Naturwissenschaftliche charakteisierung der peloide. Kompendium der Balneologie und Kurortmedizin, Steinkopff Verlag Dermstadt, 1989, p. 95-105.2. Odabasi E, Turan M, Erdem H, Tekbas F. Does mud pack treatment have any chemical effect? a randomized contralled clinical study. J Altern Complement Med. 2008; 14(5):559-65.
3. Curri SB, Bombardelli E, Grossi F. Observations on organic components of thermal mud: morphohistochemical and biochemical studies on lipid components of mud of the Terme dei Papi (Laghetto del Bagnaccio, Viterbo). Chemical bases of the interpretation of biological and therapeutic actions of thermal mud. Clin Ter. 1997; 148(12):637-54.
4. Tolomio C, Ceschi-Berrini C, Moschin E, Galzigna L. Colonization by diatoms and antirheumatic activity of thermal mud. Cell Biochem Funct. 1999; 17(1):29-33.
5. Beer AM, Sagorchev P, Lukanov J. Isolation of biologically active fractions from the water soluble components of fulvic and ulmic acids from peat. Phytomedicine. 2002; 9(7):659-66.
6. Beer AM, Junginger HE, Lukanov J, Sagorchev P. Evaluation of the permeation of peat substances through human skin in vitro. Int J Pharm. 2003; 253(1-2):169-75.
7. Odabasi E, Gul H, Macit E, Turan M, Yildiz O. Lipophilic components of different therapeutic mud species. J Altern Complement Med. 2007; 13(10):1115-8.
8. Suarez M, Gonzalez P, Dominguez R, Bravo A, Melian C, Perez M, Herrera I, Blanco D, Hernandez R, Fagundo JR.Identification of organic compounds in San Diego de los Banos Peloid (Pinar del Río, Cuba). J Altern Complement Med. 2011;17(2):155-65.
9. Eichelsdörfer D. Moor in der Kurotmedizin [Moor mud in spa medicine.]: In Moor und Torfkunde, E. Stuttgart: Schweizerbart'sche Verlagsbuchhandlung, 1990. 10. Kim JH, Lee J, Lee HB, Shin JH, Kim EK. Waterretentive and anti-inflammatory properties of organic and inorganic substances from Korean sea mud. Nat Prod Commun. 2010; 5(3):395-8.
11. Junek R, Morrow R, Schoenherr JI, Schubert R, Kallmeyer R, Phull S, Klöcking R. Bimodal effect of humic acids on the LPS-induced TNF-alpha release from differentiated U937 cells. Phytomedicine. 2009; 16(5):470-6.
12. Gau RJ, Yang HL, Chow SN, Suen JL, Lu FJ. Humic acid suppresses the LPS-induced expression of cell-surface adhesion proteins through the inhibition of NF-kappaB activation. Toxicol Appl Pharmacol. 2000; 166(1):59-67.
13. Gandy JJ, Snyman JR, van Rensburg CE. Randomized, parallel-group, double-blind, controlled study to evaluate the efficacy and safety of carbohydrate-derived fulvic acid in topical treatment of eczema. Clin Cosmet Investig Dermatol. 2011; 4:145-8.
14. van Rensburg CE, van Straten A, Dekker J. An in vitro investigation of the antimicrobial activity of oxifulvic acid. J Antimicrob Chemother. 2000 ;46(5):853. 15. Beer AM, Lukanov J, Sagorchev P. The influence of fulvic and ulmic acids from peat, on the spontaneous contractile activity of smooth muscles. Phytomedicine. 2000; 7(5):407-15.
16. Godden B, Ball A, Helvenstein P, McCarthy AJ, Penninckx MJ. Towars elucidation of lignin degradation pathway in actinomycetes. J General Microb. 1992; 138:2441-8.
17. Sawada, T, Nakamura Y, Kobayashi F, Kuwahara M, Watanabe T. Effects of fungal pretreatment and steam explosion pretreatment on enzymatic saccharification of plant biomass. Biotechnology and Bioengineering. 1995; 48:719- 724.
18. Vinardell MP, Ugartondo V. Mitjans M. Potential applications of antioxidant lignins from different sources. Industrial Crops and Products. 2008; 27: 220-223.
19. Ugartondo V, Mitjans M, Vinardell MP. Comparative antioxidant and cytotoxic effects of lignins from different sources. Bioresour Technol. 2008; 99(14):6683-7.
20. Mitsuhashi S, Kishimoto T, Uraki Y, Okamoto T, Ubukata M. Low molecular weight lignin suppresses activation of NF-kappaB and HIV-1 promoter. Bioorg Med Chem. 2008; 16(5):2645- 50. 21. Mauricio T, Karmon Y, Khaiat A. A randomized and placebo-controlled study to compare the skinlightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream. J Cosmet Dermatol. 2011; 10(4):253-9.
22. Mukherjee PK, Maity N, Nema NK, Sarkar BK. Bioactive compounds from natural resources against skin aging. Phytomedicine. 2011; 19(1):64-73. 23. Lo C, Lai TY, Yang JS, Yang JH, Ma YS, Weng SW, Lin HY, Chen HY, Lin JG, Chung JG.Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. Melanoma Res. 2011; 21(4):267-73.
24. Fiuza SM, Gomes C, Teixeira LJ, Girão da Cruz MT, Cordeiro MN, Milhazes N, Borges F, Marques MP. Phenolic acid derivatives with potential anticancer properties--a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg Med Chem. 2004;12(13):3581-9.
25. Murase T, Kume N, Hase T, Shibuya Y, Nishizawa Y, Tokimitsu I, Kita T. Gallates Inhibit Cytokine- Induced Nuclear Translocation of NF-?B and Expression of Leukocyte Adhesion Molecules in Vascular Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology.1999; 19: 1412- 1420.
26. Kim YJ. Antimelanogenic and antioxidant properties of gallic acid. Biol Pharm Bull. 2007; 30(6):1052-5.
27. Panich U, Onkoksoong T, Limsaengurai S, Akarasereenont P, Wongkajornsilp A. UVAinduced melanogenesis and modulation of glutathione redox system in different melanoma cell lines: The protective effect of gallic acid. J Photochem Photobiol B 2012; 108:16-22.
28. Chae HS, Kang OH, Choi JG, Oh YC, Lee YS, Brice OO, Chong MS, Lee KN, Shin DW, Kwon DY. Methyl gallate inhibits the production of interleukin-6 and nitric oxide via down-regulation of extracellular-signal regulated protein kinase in RAW 264.7 cells. Am J Chin Med. 2010; 38(5):973-83.
29. Santos AR, De Campos RO, Miguel OG, CechinelFilho V, Yunes RA, Calixto JB. The involvement of K+ channels and Gi/o protein in the antinociceptive action of the gallic acid ethyl ester. Eur J Pharmacol. 1999; 379(1):7-17.
30. Pluemsamran T, Onkoksoong T, Panich U. Caffeic acid and ferulic acid inhibit UVA-induced matrix metalloproteinase-1 through regulation of antioxidant defense system in keratinocyte HaCaT cells. Photochem Photobiol. 2012. Online; doi: 10.1111/j.1751-1097.
31. Staniforth V, Huang WC, Aravindaram K, Yang NS. Ferulic acid, a phenolic phytochemical, inhibits UVB-induced matrix metalloproteinases in mouse skin via posttranslational mechanisms. J Nutr Biochem. 2011 online http://dx.doi.org/10.1016/j.jnutbio.2011.01.009 32. Barone E, Calabrese V, Mancuso C. Ferulic acid and its therapeutic potential as a hormetin for agerelated diseases. Biogerontol. 2009; 10:97-108.
33. Chanda S, Bashir M, Babbar S, Koganti A, and Bley K. In Vitro Hepatic and Skin Metabolism of Capsaicin. American Society for Pharmacology and Experimental Therapeutics. 2008; 36: 670- 675.
34. Kuenzi FM, Dale N. Effect of capsaicin and analogues an potassium and calcium currents and vanilloid receptors in Xenopus embryo spinal neurones. British Journal of Pharmacology. 1996; 119,81-90.
35. Itoh A, Isoda K, Kondoh M, Kawase M, Watari A, Kobayashi M, Tamesada M, Yagi K. Hepatoprotective effect of syringic acid and vanillic acid on CCl4-induced liver injury. Biol Pharm Bull. 2010; 33(6):983-7.
36. Itoh A, Isoda K, Kondoh M, Kawase M, Kobayashi M, Tamesada M, Yagi K.Hepatoprotective effect of syringic acid and vanillic acid on concanavalin ainduced liver injury. Biol Pharm Bull. 2009; 32(7):1215-9.
37. Chou TH, Ding HY, Lin RJ, Liang JY, Liang CH.Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).J Nat Prod. 2010; 73(11):1767-74.
38. Cichocki M, Blumczynska J, Baer-Dubowska W. Naturally occurring phenolic acids inhibit 12-Otetradecanoylphorbol-13-acetate induced NFkappaB, iNOS and COX-2 activation in mouse epidermis.Toxicology. 2010; 268(1-2):118-24.
39. Mandalari G, Bisignano C, D'Arrigo M, Ginestra G, Arena A, Tomaino A, Wickham MS. Antimicrobial potential of polyphenols extracted from almond skins.Lett Appl Microbiol. 2010; 51(1):83-9.
40. Maity N, Nema NK, Abedy MK, Sarkar BK, Mukherjee PK. Exploring Tagetes erecta Linn flower for the elastase, hyaluronidase and MMP-1 inhibitory activity. J Ethnopharmacol. 2011; 137(3): 1300-5.
41. Parmar A, Singh K, Bahadur A, Marangoni G, Bahadur P. Interaction and solubilization of some phenolic antioxidants in Pluronic micelles. Colloids Surf B Biointerfaces. 2011; 86(2):319-26.
42. Nakagawa K, Anzai K. Stratum corneum lipid structure investigated by EPR spin-probe method: application of terpenes. Lipids. 2010; 45(11):1081-7. 43. Camargos HS, Silva AH, Anjos JL, Alonso A. Molecular dynamics and partitioning of di-tert-butyl nitroxide in stratum corneum membranes: effect of terpenes. Lipids. 2010; 45(5):419-27.
44. Magnusson BM, Runn P, Koskinen LO. Terpeneenhanced transdermal permeation of water and ethanol in human epidermis. Acta Derm Venereol. 1997; 77(4):264-7.
45. Moreira MR, Cruz GMP, Lopes MS, Albuquerque AAC. and Leal-Cardoso JH .Effects of terpineol on the compound action potential of the rat sciatic nevre. Braz J Med Biol Res. 2001; 34(10) 1337- 1340.
46. Quintans-Júnior LJ, Oliveira MG, Santana MF, Santana MT, Guimarães AG, Siqueira JS, De Sousa DP, Almeida RN. ?-Terpineol reduces nociceptive behavior in mice. Pharm Biol. 2011; 49(6):583-6.
47. Szalli A, Blumberg PM. Vaniloid(capsaicin) receptors and mechanisms. Pharmacological Reviews. 1999; 51:159-212.
48. Bicas JL, Neri-Numa IA, Ruiz AL, De Carvalho JE, Pastore GM. Evaluation of the antioxidant and antiproliferative potential of bioflavors. Food Chem Toxicol. 2011;49(7):1610-5.
49. Hassan SB, Gali-Muhtasib H, Göransson H, Larsson R. Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling. Anticancer Res. 2010; 30(6):1911-9.
50. Ribeiro TP, Porto DL, Menezes CP, Antunes AA, Silva DF, De Sousa DP, Nakao LS, Braga VA, Medeiros IA. Unravelling the cardiovascular effects induced by alpha-terpineol: a role for the nitric oxide-cGMP pathway. Clin Exp Pharmacol Physiol. 2010; 37(8):811-6.
51. Tajino K, Matsumura K, Kosada K, Shibakusa T, Inoue K, Fushiki T, Hosokawa H, Kobayashi S. Application of menthol to the skin of whole trunk in mice induces autonomic and behavioral heat-gain responses. Am J Physiol Regul Integr Comp Physiol. 2007;293(5):2128-35.
52. Tajino K, Hosokawa H, Maegawa S, Matsumura K, Dhaka A, Kobayashi S. Cooling-sensitive TRPM8 is thermostat of skin temperature against cooling. PLoS One. 2011 2;6(3):e17504.
53. Patel T, Yosipovitch G. The management of chronic pruritus in the elderly. Skin Therapy Lett. 2010;15(8):5-9.
54. Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs. 2006;18(3):227-33 55. Pokharkar V, Dhar S, Singh N. Effect of penetration enhancers on gel formulation of Zidovudine: in vivo and ex vivo studies. PDA J Pharm Sci Technol. 2010;64(4):337-47.
56. Gaudioso C, Hao J, Martin-Eauclaire MF, Gabriac M, Delmas P. Menthol pain relief through cumulative inactivation of voltage-gated sodium channels. Pain. 2012;153(2):473-84.
57. Su L, Wang C, Yu YH, Ren YY, Xie KL, Wang GL. Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain. BMC Neurosci. 2011,23;12:120.
58. Borhani Haghighi A, Motazedian S, Rezaii R, Mohammadi F, Salarian L, Pourmokhtari M, Khodaei S, Vossoughi M, Miri R. Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study. Int J Clin Pract. 2010; 64(4):451-6.
59. Myrer JW, Johnson AW, Mitchell UH, Measom GJ, Fellingham GW. Topical analgesic added to paraffin enhances paraffin bath treatment of individuals with hand osteoarthritis. Disabil Rehabil. 2011; 33(6):467-74.
60. Higashi Y, Kiuchi T, Furuta K. Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: a randomized, double-blind, parallel-group, placebo-controlled, multicenter study. Clin Ther. 2010; 32(1):34-43.
61. Pappas A. Epidermal surface lipids. Dermatoendocrinol. 2009; 1(2):726.
62. Huang ZR, Lin YK, Fang JY. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules. 2009 23;14:540-54.
63. Pappas A, Johnsen S, Liu JC, Eisinger M. Sebum analysis of individuals with and without acne. Dermatoendocrinol. 2009;1(3):157-61.
64. Kim MJ, Doh HJ, Choi MK, Chung SJ, Shim CK, Kim DD, Kim JS, Yong CS, Choi HG. Skin permeation enhancement of diclofenac by fatty acids. Drug Deliv. 2008;15(6):373-9.
65. Khalil MH, Marcelletti JF, Katz LR, Katz DH, Pope LE. Topical application of docosanol- or stearic acid-containing creams reduces severity of phenol burn wounds in mice. Contact Dermatitis. 2000; 43(2):79-81.
66. Guillard EC, Laugel C, Baillet-Guffroy A. Molecular interactions of penetration enhancers within ceramides organization: a FTIR approach. Eur J Pharm Sci. 2009; 36(2-3):192-9.
67. Chen CH, Wang Y, Nakatsuji T, Liu YT, Zouboulis C, Gallo R, Zhang L, Hsieh MF, Huang CM. An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine. . J Microbiol Biotechnol. 2011; 21(4):391-9.
68. Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang CM. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol. 2010;130(4):985- 94.
69. Shigeta Y, Imanaka H, Ando H, Ryu A, Oku N, Baba N, Makino T. Skin whitening effect of linoleic acid is enhanced by liposomal formulations.Biol Pharm Bull. 2004; 27(4):591-4.
70. Ziboh VA, Cho Y, Mani I, Xi S. Biological significance of essential fatty acids/prostanoids/lipoxygenase-derived monohydroxy fatty acids in the skin. Arch Pharm Res. 2002; 25(6):747-58.
71. Anand P, Bley K.Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new highconcentration capsaicin 8% patch. Br J Anaesth. 2011; 107(4):490-502.
72. Patwardhan AM, Akopian AN, Ruparel NB, Diogenes A, Weintraub ST, Uhlson C, Murphy RC, Hargreaves KMHeat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J Clin Invest. 2010; 120(5):1617- 26.
73. Sudhahar V, Shaw S, Imig JD. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries. Eur J Pharmacol. 2009; 607(1-3):143-50.